CrushSCI.com
提供学术论文选刊润色服务
CYTOTHERAPY 期刊封面 医学
返回期刊列表

Review Cycle Records

CYTOTHERAPY

Elsevier SCIE 非OA
2026新锐 3区2025中科院 3区2025 JCR Q2
98.2平均天数
93中位天数
44最短天数
148最长天数
7622025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

83 天

Safety and tolerability of topical mesenchymal stromal cell secretome in persistent corneal epithelial disease—a phase 1b clinical trial

作者Farshad Abedi; Jeonghyun (Esther) Kwon; Iskra Araujo; Zarife J. Yucel; Rebecca Jung; Mohammad Soleimani; Seungwon An; Mahmood Ghassemi; Khandeker N Anwar; Zohreh Arabpour; Monazzah A. Sarwar; Elmer Y. Tu; Peiman Hematti; Charlotte E. Joslin; Nadim Mahmud; Ali R. Djalilian

作者单位Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago, Illinois, USA; Division of Hematology/Oncology, Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois, USA; Department of Pharmacy Practice, Retzky College of Pharmacy, University of Illinois, Chicago, Illinois, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Division of Epidemiology and Biostatistics, University of Illinois at Chicago

PDF源文件 DOI 网页
44 天

Sequential CD2/CD3/CD28 activation improves nonviral large-payload chimeric antigen receptor knock-in at the T cell receptor α constant locus

作者Wei Wen; Xiang Li; Tong Liu; Shu-Man Zhang; Di Sun; Xi-Die Zhao; Chong-Yan Cheng; Li-Ming Zhang; Jian-Ping Zhang; Xiao-Bing Zhang

作者单位State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin, China

PDF源文件 DOI 网页
109 天

Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease

作者Masahiro Teramoto; Yoshimitsu Shimomura; Masamitsu Yanada; Shohei Mizuno; Koji Nagafuji; Hirohisa Nakamae; Masao Ogata; Noboru Asada; Tetsuya Eto; Toshihiko Ando; Atsushi Wake; Masatsugu Tanaka; Masashi Sawa; Naoyuki Uchida; Yuta Hasegawa; Masahito Tokunaga; Hideki Nakasone; Fumihiko Ishimaru; Junya Kanda; Yoshiko Atsuta; Takaaki Konuma

作者单位Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan; Division of Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu, Japan; Department of Hematology, Okayama University Hospital, Okayama, Japan; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital Kajigaya, Kawasaki, Japan; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

PDF源文件 DOI 网页
103 天

Multicenter validation study on post-thaw viability testing of cryopreserved hematopoietic progenitor cell products

作者Wanxing Cui; Cheryl Cox; Kevin Land; Serey-Phorn Sea; Qingdong Guan; Anginett Batista; Yuki Cui; Angeline Giftakis; Nasreen Haroon; Brett Keefe; Kumar Karyampudi; Darryl Miciano; Rachel Murillo; Melba Marie Page; Marie Tulloch; Federico Rodriguez; Ronit Reich-Slotky; Nadim Mahmud; Joseph Schwartz

作者单位Cell Therapy Manufacturing Facility, MedStar Georgetown University Hospital, Washington, DC, USA; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA; Vitalant Cellular Therapy Lab, Tempe, Arizona, USA; CHU de Québec–Université Laval, Québec City, Québec, Canada; Health Sciences Centre, Winnipeg, Manitoba, Canada; Orlando Health Cancer Institute, Orlando, Florida, USA; Georgetown University School of Medicine, Washington, DC, USA; Hackensack University Medical Center, Hackensack, New Jersey, USA; University of Illinois Hospital and Health Sciences System (UI Health), Chicago, Illinois, USA; Foundation for the Accreditation of Cellular Therapy, Omaha, Nebraska, USA

PDF源文件 DOI 网页
122 天

Human mesenchymal stromal cell extracellular vesicles maintain therapeutic miRNA cargo despite exposure to cystic fibrosis bronchoalveolar lavage fluid

作者Sara Rolandsson Enes; Thomas H. Hampton; Jayita Barua; Zeta Mui; Tobias Tertel; Bernd Giebel; David H. McKenna; Pingzhao Hu; Alix Ashare; Bruce A. Stanton; Claudia C. Dos Santos; Daniel J. Weiss

作者单位Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA; Department of Experimental Medical Science, Lund University, Lund, Sweden; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA; Department of Medicine and the Keenan Center for Biomedical Research, Interdepartmental Division of Critical Care, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Institute of Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen Germany; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA; Dept of Biochemistry, Western University, London, Ontario, Canada; Section of Pulmonary and Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

PDF源文件 DOI 网页
76 天

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework

作者Dominik Griebling; Anna Rebecca Scheiwe; Ralf Kuhlen; Chloé Zech; Pia Müller; Christian Rische; Vivian Längst; Chris Wegener; Lexie Schmidt; Paige Bothwell; Kyle Thompson; Katrin Mestermann; Carmen Sanges; David Krones; Mirko Müller; Anna Dünkel; Michael Hudecek; Ulrike Köhl; Ayal Hendel; Dmitry Kashanin; Vivienne Williams; Julia Schüler; Natacha Bolaños; Louise McNamara; Tuula Rintala; Anna Sureda; Afschin Gandjour; Theresa D. Ahrens; Patrick Mennig; Eduard Christiaan Groen; Bertram Glass; Agnes Vosen; Julia Busch-Casler; Marija Radic; Anika Teichert; Ralf Hoffmann; Thomas Brzoska; Catrina Pietralla; Jens O. Brunner; Theresa Kagerbauer; Christin Zündorf; George S. Baillie; Nattaporn Phanthaphol; Felipe Prósper; Juan R. Rodriguez Madoz; Cristina Carames; Sonja Steppan

作者单位Fresenius SE & Co. KGaA, Bad Homburg, Germany; Fresenius Kabi, Lake Zurich, Illinois 60047, USA; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany; Institute of Nanotechnology and Advanced Materials, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Safed, Israel; Cellix Limited, Dublin, Ireland; Charles River Laboratories Germany GmbH, Freiburg, Germany; European Society for Blood and Marrow Transplantation, Barcelona, Spain; Frankfurt School of Finance & Management, Germany; Fraunhofer Institute for Experimental Software Engineering IESE, Kaiserslautern, Germany; Helios Hospital Berlin-Buch GmbH, Berlin, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Philips Intellectual Property & Standards, Eindhoven, The Netherlands; Pro-Liance Global Solutions GmbH, Münster, Germany; Technical University of Denmark (DTU), Kongens Lyngby, Copenhagen, Denmark; TQ Therapeutics GmbH, Munich, Germany; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), 31009, Pamplona, Spain; Hemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), IdiSNA, Pamplona, Spain; Quirónsalud Healthcare Network, Madrid, Spain

PDF源文件 DOI 网页
68 天

Automated expansion of iPSCs enables scalable extracellular vesicle production with anti-senescence bioactivity

作者Toshihiko Nambara; Tammee M. Parsons; Ana-Caroline Raulin; Angelica Gaona; Bhaskar Roy; Takahisa Kanekiyo

作者单位Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA

PDF源文件 DOI 网页
81 天

Higher yields of Vγ9Vδ2 T cells from peripheral blood than umbilical cord blood via interleukin-12 and interleukin-18

作者Shih-Feng Cho; Wan-En Liao; Yi-Chang Liu; Te-Fu Chan; Shian-Ren Lin; Chia-Chun Tu; Ya-Fang Cheng; Chih-Hao Fang; Yuan-Yuan Huang; Shiu-Lan Wang; Wan-Yu Lai; Yee Chao; Li-Tzong Chen; Jan-Mou Lee

作者单位Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80738, Taiwan; FullHope Biomedical Co. Ltd., New Taipei City, Taiwan; Department of Gynecology and Obstetrics, Kaohsiung Medical University Hospital, Kaohsiung, 80756, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research and College of Medicine, Kaohsiung Medical University, Kaohsiung, 80738, Taiwan

PDF源文件 DOI 网页
148 天

Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease

作者Makoto Murata; Seitaro Terakura; Junya Kanda; Naoyuki Uchida; Satoshi Yoshihara; Takahiro Fukuda; Keisuke Kataoka; Atsushi Wake; Noriko Doki; Shuichi Ota; Maho Sato; Masahito Tokunaga; Yasuo Mori; Hirohisa Nakamae; Moeko Hino; Makoto Onizuka; Ken Tabuchi; Yoshiko Atsuta; Takanori Teshima

作者单位Department of Hematology, Shiga University of Medical Science, Otsu, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Hematology, Kyoto University, Kyoto, Japan; Department of Hematology, Toranomon Hospital, Tokyo, Japan; Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan; Department of Hematology, Toranomon Hospital, Kajigaya Kawasaki, Tokyo, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan; Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Izumi, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan; Department of Pediatrics, School of Medicine, Chiba University, Chiba, Japan; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

PDF源文件 DOI 网页
148 天

MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression

作者Serap Gokcen; Tianyuan Chu; Phoebe Elizabeth Blair; Natalia Magdalena Krajewska; Greg Nicholas Brooke; Stuart Rushworth; Philippe Pierre Laissue; Ralf Michael Zwacka; Andrea Mohr

作者单位School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Cancer and Stem Cell Biology Group, University of Essex, Colchester, UK; School of Life Sciences, Protein Structure and Mechanisms of Disease Group, Molecular Oncology Laboratory, University of Essex, Colchester, UK; Metabolic Health Research Centre, Norwich Medical School, University of East Anglia, Norwich, UK; School of Life Sciences, Bioimaging Facility, University of Essex, Colchester, UK

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。